HCA Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	75,600	70,603	64,968	60,233	58,752
Revenue Growth (YoY)	7.08%	8.67%	7.86%	2.52%	14.01%
Cost of Revenue	44,226	41,925	39,389	37,056	36,260
Gross Profit	31,374	28,678	25,579	23,177	22,492
Selling, General & Admin	-	1,049	994	976	989
Other Operating Expenses	15,886	13,770	11,882	10,178	8,972
Operating Expenses	19,409	18,131	15,953	14,123	12,814
Operating Income	11,965	10,547	9,626	9,054	9,678
Interest Expense	-2,248	-2,061	-1,938	-1,741	-1,566
Earnings From Equity Investments	78	23	22	45	113
EBT Excluding Unusual Items	9,795	8,509	7,710	7,358	8,225
Gain (Loss) on Sale of Investments	-	-	1	-1	-
Gain (Loss) on Sale of Assets	37	14	-5	1,301	1,620
Other Unusual Items	-	-	-	-78	-12
Pretax Income	9,832	8,523	7,706	8,580	9,833
Income Tax Expense	2,050	1,866	1,615	1,746	2,112
Earnings From Continuing Operations	7,782	6,657	6,091	6,834	7,721
Minority Interest in Earnings	-998	-897	-849	-1,191	-765
Net Income	6,784	5,760	5,242	5,643	6,956
Net Income to Common	6,784	5,760	5,242	5,643	6,956
Net Income Growth	17.78%	9.88%	-7.11%	-18.88%	85.30%
Shares Outstanding (Basic)	239	259	272	290	323
Shares Outstanding (Diluted)	239	262	276	295	329
Shares Change (YoY)	-8.52%	-5.28%	-6.19%	-10.37%	-4.32%
EPS (Basic)	28.33	22.27	19.24	19.44	21.51
EPS (Diluted)	28.33	22.00	18.97	19.15	21.16
EPS Growth	28.76%	15.97%	-0.94%	-9.50%	93.60%
Free Cash Flow	7,692	5,639	4,687	4,127	5,382
Free Cash Flow Per Share	32.12	21.54	16.96	14.01	16.37
Dividend Per Share	2.880	2.640	2.400	2.240	1.920
Dividend Growth	9.09%	10.00%	7.14%	16.67%	346.51%
Gross Margin	41.50%	40.62%	39.37%	38.48%	38.28%
Operating Margin	15.83%	14.94%	14.82%	15.03%	16.47%
Profit Margin	8.97%	8.16%	8.07%	9.37%	11.84%
Free Cash Flow Margin	10.17%	7.99%	7.21%	6.85%	9.16%
EBITDA	15,488	13,859	12,703	12,023	12,531
EBITDA Margin	20.49%	19.63%	19.55%	19.96%	21.33%
D&A For EBITDA	3,523	3,312	3,077	2,969	2,853
EBIT	11,965	10,547	9,626	9,054	9,678
EBIT Margin	15.83%	14.94%	14.82%	15.03%	16.47%
Effective Tax Rate	20.85%	21.89%	20.96%	20.35%	21.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.